Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Evommune, Inc. | 47,845 | reported | 28 May 2026 | tx 7+310,894−67,070 |
| Anteris Technologies Global Corp. | 13,821 | reported | 03 Dec 2025 | tx 2+66,563 |
| Kadmon Holdings, LLC | 0 | reported | 09 Nov 2021 | tx 11+1,340,000−1,657,871 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | EXERCISE | Evommune, Inc. | 14,223 | 1.71 USD | 10b5-1 |
| 28 May 2026 | SALE | Evommune, Inc. | 14,223 | 22.83 USD | 10b5-1 |
| 28 May 2026 | EXERCISE | Evommune, Inc. | 14,223 | 0.00 USD | 10b5-1deriv |
| 09 Dec 2025 | TAX_WITHHOLDING | Evommune, Inc. | 13,624 | 17.84 USD | |
| 03 Dec 2025 | GRANT_AWARD | Anteris Technologies Global Corp. | 13,821 | 0.00 USD | deriv |
| 03 Dec 2025 | GRANT_AWARD | Anteris Technologies Global Corp. | 52,742 | 0.00 USD | deriv |
| 07 Nov 2025 | CONVERSION | Evommune, Inc. | 3,175 | — | |
| 07 Nov 2025 | CONVERSION | Evommune, Inc. | 25,000 | — | deriv |
| 05 Nov 2025 | GRANT_AWARD | Evommune, Inc. | 293,496 | 0.00 USD | deriv |
| 09 Nov 2021 | OTHER | Kadmon Holdings, LLC | 17,671 | 9.50 USD | |
| 09 Nov 2021 | OTHER | Kadmon Holdings, LLC | 75,000 | 7.03 USD | deriv |
| 09 Nov 2021 | OTHER | Kadmon Holdings, LLC | 75,000 | 4.84 USD | deriv |
| 09 Nov 2021 | OTHER | Kadmon Holdings, LLC | 150,000 | 5.86 USD | deriv |
| 09 Nov 2021 | OTHER | Kadmon Holdings, LLC | 200 | 3.50 USD | deriv |
| 09 Nov 2021 | OTHER | Kadmon Holdings, LLC | 300,000 | 7.36 USD | deriv |
| 09 Nov 2021 | OTHER | Kadmon Holdings, LLC | 360,000 | 5.16 USD | deriv |
| 09 Nov 2021 | OTHER | Kadmon Holdings, LLC | 680,000 | 5.54 USD | deriv |
| 08 Jan 2021 | GRANT_AWARD | Kadmon Holdings, LLC | 680,000 | 0.00 USD | deriv |
| 27 Jan 2020 | GRANT_AWARD | Kadmon Holdings, LLC | 360,000 | 0.00 USD | deriv |
| 30 Aug 2019 | GRANT_AWARD | Kadmon Holdings, LLC | 300,000 | 2.14 USD | deriv |